<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">JIC</journal-id>
         <journal-id journal-id-type="hwp">spjic</journal-id>
         <journal-id journal-id-type="nlm-ta">J Intensive Care Med</journal-id>
         <journal-title>Journal of Intensive Care Medicine</journal-title>
         <issn pub-type="ppub">0885-0666</issn>
         <issn pub-type="epub">1525-1489</issn>
         <publisher>
            <publisher-name>SAGE Publications</publisher-name>
            <publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.1177/0885066612444261</article-id>
         <article-id pub-id-type="publisher-id">10.1177_0885066612444261</article-id>
         <article-categories>
            <subj-group subj-group-type="heading">
               <subject>Original Research</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title>Characteristics of Patients With the “Malignant Obesity Hypoventilation Syndrome” Admitted to an ICU</article-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" corresp="yes" xlink:type="simple">
               <name name-style="western">
                  <surname>Marik</surname>
                  <given-names>Paul E.</given-names>
               </name>
               <degrees>MD, FCCM, FCCP, ABPNS</degrees>
               <xref ref-type="aff" rid="aff1-0885066612444261">1</xref>
               <xref ref-type="corresp" rid="corresp1-0885066612444261"/>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Desai</surname>
                  <given-names>Himanshu</given-names>
               </name>
               <degrees>MD</degrees>
               <xref ref-type="aff" rid="aff1-0885066612444261">1</xref>
            </contrib>
         </contrib-group>
         <aff id="aff1-0885066612444261">
            <label>1</label>Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA, USA</aff>
         <author-notes>
            <corresp id="corresp1-0885066612444261">Paul E. Marik, Department of Medicine, Eastern Virginia Medical School, 825 Fairfax Ave, Suite 410, Norfolk, VA 23507, USA. Email: <email xlink:type="simple">marikpe@evms.edu</email>
            </corresp>
         </author-notes>
         <pub-date pub-type="epub-ppub">
            <month>3</month>
            <year>2013</year>
         </pub-date>
         <volume>28</volume>
         <issue>2</issue>
         <fpage>124</fpage>
         <lpage>130</lpage>
         <history>
            <date date-type="received">
               <day>15</day>
               <month>9</month>
               <year>2011</year>
            </date>
            <date date-type="rev-recd">
               <day>17</day>
               <month>10</month>
               <year>2011</year>
            </date>
         </history>
         <permissions>
            <copyright-statement>© The Author(s) 2012</copyright-statement>
            <copyright-year>2012</copyright-year>
            <copyright-holder content-type="sage">SAGE Publications</copyright-holder>
         </permissions>
         <abstract>
            <sec>
               <title>Background:</title>
               <p>The incidence of obesity in westernized nations is increasing at an alarming rate. We have noted an increasing number of patients admitted to our intensive care unit (ICU) with hypercapnic respiratory failure and multisystem organ dysfunction related to obesity. We have coined the term the malignant obesity hypoventilation syndrome (MOHS) to describe this entity.</p>
            </sec>
            <sec>
               <title>Methods:</title>
               <p>We reviewed the hospital records of all patients who were admitted to our ICU over an 8-month period, with a body mass index (BMI) greater than 40 kg/m<sup>2</sup> and a PaCO<sub>2</sub> greater than 45 mm Hg. We excluded patients with musculoskeletal disease, intrinsic lung disease, and those with &gt;20 pack-year smoking history.</p>
            </sec>
            <sec>
               <title>Results:</title>
               <p>Sixty-one patients (8% of all admissions) met the inclusion criteria for our study. The patients’ mean BMI was 48.9 ± 8.6 kg/m<sup>2</sup>. The patients’ mean age was 59 ± 11; 47 (77%) were female and 56 (92%) were black. All patients were admitted to the ICU with hypercapnic respiratory failure. The patients had been admitted to our hospital on average 6 times over the previous 2 years; 75% had been erroneously diagnosed and treated for chronic obstructive pulmonary disease (COPD)/asthma and 86% had been treated with diuretics for congestive cardiac failure. All patients had type 2 diabetes and the metabolic syndrome. Three patients had a tracheotomy in place at admission and required mechanical ventilation. All of the remaining patients were treated with noninvasive bilevel positive airway pressure (BiPAP), with 23 patients failing BiPAP and requiring mechanical ventilation. Seven patients had a tracheotomy performed. On the basis of unexplained abnormalities of liver function tests, 39 patients (64%) were presumptively diagnosed with nonalcoholic steatohepatitis (NASH). Pulmonary function tests were suggestive of a restrictive pattern in all patients tested. By echocardiography 43 (71%) patients had left ventricular hypertrophy and 37 (61%) patients had features of left ventricular diastolic dysfunction. Forty-seven (77%) patients had pulmonary hypertension, which was moderate to severe (pulmonary systolic pressure &gt;45 mm Hg) in 25 cases. All patients had an elevated C-reactive protein (9.4 ± 6.9 mg/dL), and all but 1 were vitamin D deficient (13.5 ± 8.5 ng/mL). Eleven patients (18%) died during the index hospitalization.</p>
            </sec>
            <sec>
               <title>Conclusions:</title>
               <p>MOHS is a serious multisystem disorder with a high mortality that appears to be relatively common, frequently misdiagnosed, and inadequately treated.</p>
            </sec>
         </abstract>
         <kwd-group>
            <kwd>obesity</kwd>
            <kwd>Pickwickian</kwd>
            <kwd>obesity hypoventilation syndrome</kwd>
            <kwd>metabolic syndrome</kwd>
            <kwd>nonacholic steatohepatitis</kwd>
            <kwd>pulmonary hypertension</kwd>
            <kwd>myocardial hypotrophy</kwd>
            <kwd>diastolic heart failure</kwd>
            <kwd>diabetes</kwd>
            <kwd>vitamin D deficiency</kwd>
         </kwd-group>
         <custom-meta-wrap>
            <custom-meta xlink:type="simple">
               <meta-name>cover-date</meta-name>
               <meta-value>March/April 2013</meta-value>
            </custom-meta>
         </custom-meta-wrap>
      </article-meta>
   </front>
   <body>
      <p>We are in the midst of a worldwide obesity pandemic, with the United States being the epicenter.<sup>
            <xref ref-type="bibr" rid="bibr1-0885066612444261">1</xref>,<xref ref-type="bibr" rid="bibr2-0885066612444261">2</xref>
         </sup> Obesity is an independent predictor of the development of type 2 diabetes, hypertension, cardiac disease, the metabolic syndrome, obstructive sleep apnea (OSA), malignancy as well as cerebrovascular, liver, and kidney disease.<sup>
            <xref ref-type="bibr" rid="bibr3-0885066612444261">3</xref>
            <xref ref-type="bibr" rid="bibr4-0885066612444261"/>–<xref ref-type="bibr" rid="bibr5-0885066612444261">5</xref>
         </sup> The risk of death from all causes increases throughout the range of moderate and severe overweight for both men and women in all age groups.<sup>
            <xref ref-type="bibr" rid="bibr3-0885066612444261">3</xref>
            <xref ref-type="bibr" rid="bibr4-0885066612444261"/>–<xref ref-type="bibr" rid="bibr5-0885066612444261">5</xref>
         </sup>
      </p>
      <p>Obesity hypoventilation syndrome (OHS) refers to the appearance of awake hypercapnia (PaCO<sub>2</sub> &gt; 45 mm Hg) in the obese patient (BMI &gt;30 kg/m<sup>2</sup>) after other causes that could account for awake hypoventilation, such as lung or neuromuscular disease, have been excluded.<sup>
            <xref ref-type="bibr" rid="bibr6-0885066612444261">6</xref>
         </sup> The incidence of OHS increases significantly as the prevalence of obesity increases, with a reported prevalence of between 10% and 20% in outpatients presenting to sleep clinics and 30% in hospitalized obese patients.<sup>
            <xref ref-type="bibr" rid="bibr6-0885066612444261">6</xref>
            <xref ref-type="bibr" rid="bibr7-0885066612444261"/>
            <xref ref-type="bibr" rid="bibr8-0885066612444261"/>
            <xref ref-type="bibr" rid="bibr9-0885066612444261"/>–<xref ref-type="bibr" rid="bibr10-0885066612444261">10</xref>
         </sup> The syndrome is postulated to result from complex interactions between impaired respiratory mechanics, abnormal central ventilatory control, sleep-disordered breathing, and neurohormonal (leptin resistance) and endocrine aberrancies (insulin resistance, low progesterone).<sup>
            <xref ref-type="bibr" rid="bibr6-0885066612444261">6</xref>
         </sup> It is likely that the vast majority of patients with OHS remain undiagnosed.<sup>
            <xref ref-type="bibr" rid="bibr9-0885066612444261">9</xref>
         </sup> The OHS is distinguished from the “overlap syndrome” which is the term used to describe the association of chronic obstructive pulmonary disease (COPD) and OSA.<sup>
            <xref ref-type="bibr" rid="bibr11-0885066612444261">11</xref>
         </sup>
      </p>
      <p>We have noted an increasing number of patients admitted to our intensive care unit (ICU) with hypercapnic respiratory failure due to previously undiagnosed OHS. These patients were noted to have severe obesity-related multisystem organ dysfunction. The purpose of the present study is to describe this poorly recognized and potentially fatal clinical syndrome which we have called the malignant obesity hypoventilation syndrome (MOHS). We consider MOHS a subgroup of OHS in which the higher BMI (&gt;40 kg/m<sup>2</sup>) may account for the greater multiorgan system dysfunction and morbidity.</p>
      <sec id="section1-0885066612444261" sec-type="methods">
         <title>Methods</title>
         <p>We performed a retrospective electronic chart review of patients admitted to the General ICU (GICU) at Sentara Norfolk General Hospital between September 2010 and April 2011. This study was approved by our Institutional Review Board. We queried our electronic medical record system to identify patients that met the following criteria on admission to the GICU (i) BMI &gt;40 kg/m<sup>2</sup> and (ii) PaCO<sub>2</sub> &gt;45 mm Hg. The BMI was calculated based on the patients’ admission height and weight. We excluded patients with &gt;20 pack-year smoking history, thoracic musculoskeletal/neuromuscular disease, intrinsic lung disease, acute pulmonary embolism, patients with drug-induced hypoventilation (opiates, sedatives, etc), or other known reasons for “day-time” hypoventilation. We excluded patients with a normal serum bicarbonate (&lt;26 mmol/L) to exclude patients without baseline chronic hypoventilation. In order to exclude acute thromoboembolic disease, all patients had lower extremity Doppler ultrasound examinations performed on admission to the ICU with computed tomography (CT) angiography performed in patients with a moderate-to high clinical probability of pulmonary embolism. Only the patient’s first admission to the ICU during this time period was recorded. De-identified clinical data including the patients’ demographics, medical history, and clinical features on presentation, as well as admission laboratory data and outcome were recorded. Chronic renal insufficiency (CRI) was defined as a baseline serum creatinine &gt;1.4 mg/dL and vitamin D deficiency as a serum 25-hydroxyvitamin D &lt;30 ng/mL.<sup>
               <xref ref-type="bibr" rid="bibr12-0885066612444261">12</xref>
            </sup> Serum ammonia (NH<sub>3</sub>) &gt;60 ug/dL and C-reactive protein (CRP) &gt;0.5 mg/dL were considered abnormal. The presumptive diagnosis of nonalcoholic steatohepatitis (NASH) was made in those patients with abnormal liver function tests in the absence of other causes of liver disease (alcohol and hepatitis B or C).</p>
         <p>Esophageal manometry was performed in those patients who required mechanical ventilation with the goal of keeping the transpulmonary pressure (alveolar pressure − esophageal pressure) positive for the duration of the respiratory cycle.<sup>
               <xref ref-type="bibr" rid="bibr13-0885066612444261">13</xref>
            </sup> We used an ACKRAD laboratory adult esophageal balloon catheter set (CooperSurgical Company, Trumbull, Connecticut) which was connected to the Hamilton Galileo and G5 ventilators (Hamilton Medical, Reno, Nevada) that allowed for continuous real-time esophageal and transpulmonary pressure monitoring. Echocardiographic data during the index admission were recorded. Although obtained for clinical care, all echocardiograms were performed following a standardized protocol. Left ventricular (LV) mass (normalized to height<sup>2.7</sup>) and relative wall thickness were calculated using standard formulae.<sup>
               <xref ref-type="bibr" rid="bibr14-0885066612444261">14</xref>
            </sup> LV mass index &gt;47 g/m<sup>2.7</sup> was considered abnormal with a relative wall thickness (RWT) of less than 0.45, indicating eccentric LV hypertrophy. Left ventricular diastolic function was assessed by mitral E/A ratio and tissue Doppler evaluation.<sup>
               <xref ref-type="bibr" rid="bibr15-0885066612444261">15</xref>
            </sup> The peak tricuspid regurgitant velocity was used to estimate the pulmonary artery systolic pressure. An estimated pulmonary artery systolic pressure greater than 35 mm Hg was considered to indicate pulmonary hypertension, while a pressure greater than 45 mm Hg was considered moderate-to-severe pulmonary hypertension. Postdischarge pulmonary function tests (PFTs) were ordered in those patients who did not have recent PFTs (within the last 2 years). The results of previously performed polysomnography (apnea–hypopnea index) were recorded. The patients’ hospital outcome and the number of admissions to our hospital in the previous 2 years were recorded.</p>
         <p>The patients’ de-identified data were recorded in a spreadsheet (Excel 2010, Microsoft, Redmond, Washington). Summary statistics were used to describe the clinical data. Chi-square analysis with Fisher exact test (when appropriate) and Student <italic>t</italic> test were used to compare data between survivors and nonsurvivors. Unless otherwise stated, all data are expressed as mean ± standard deviation (SD), with statistical significance declared for probability values of .05 or less.</p>
      </sec>
      <sec id="section2-0885066612444261">
         <title>Results</title>
         <p>During the 8-month study period 61 patients (8% of all admissions) met the inclusion criteria for this study. Forty-seven (77%) of the patients were female and 56 (92%) were black. The patients’ mean age was 59 ± 11 years (range 32-80). The mean admission BMI was 48.9 ± 8.6 kg/m<sup>2</sup> (range 41-73). All of the patients had been previously admitted to our hospital or emergency room in the preceding 24 months; the average number of admissions was 6 ± 7 (range 1-39). Each patient had an elevated PaCO<sub>2</sub> (&gt;45 mm Hg) on all previous admissions. None of the patients were current smokers; 11 had previously smoked (&lt;20 pack/years). Forty-two (68%) patients had been erroneously diagnosed and treated for COPD (bronchodilators and intermittent steroids), 4 for asthma/COPD, and 53 patients (86%) had been treated with diuretics for congestive cardiac failure. None of the patients diagnosed with COPD had evidence of obstructive airway disease and none of the patients diagnosed with asthma had evidence of reversible airway obstruction on lung function testing (see below). All patients had type 2 diabetes (HbA1C &gt; 6.1%). Twelve patients were being treated for hypothyroidism; no patients had clinical or laboratory evidence of hypothyroidism on the index admission. Fifty-five (90%) patients had been diagnosed with hypertension. All patients met the Adult Treatment Panel III (ATP-III) diagnostic criteria for the metabolic syndrome.<sup>
               <xref ref-type="bibr" rid="bibr16-0885066612444261">16</xref>
            </sup> Eight (13%) patients had a history of deep venous thrombosis. Twenty-four (40%) patients had previously undergone polysomnography, with 22 having been prescribed nocturnal CPAP/BiPAP; only 3 of these patients carried the diagnosis of OHS. Two patients had an apnea-hyponea index (AHI)&lt;10 events/h; the mean AHI in the remaining 22 patients was 81 ± 36 events/h. Per the inclusion criteria of our study, all patients presented with type II respiratory failure; the mean admission PaCO<sub>2</sub> was 69.2 ± 17.4 mm Hg, with a bicarbonate of 34.3 ± 5.1 meq/L (despite the fact that 25 patients had CRI). All patients were admitted to hospital with the diagnosis of “COPD exacerbation” and/or heart failure. The reason for ICU admission in all cases was for hypercapnic respiratory failure. Pneumonia was suspected in 9 patients, urosepsis in 2, and 4 patients had acute or chronic renal failure. In addition, 4 patients were admitted with lower limb cellulitis and 1 patient each with an embolic stroke and subacute pancreatitis (presumably due to hypertriglyceridemia). Three patients had previously had a tracheotomy performed for OSA; these patients required mechanical ventilation. All the remaining patients were treated with bilevel positive airway pressure (BiPAP), with 23 (38%) patients failing BiPAP and requiring mechanical ventilation. Esophageal manometry was performed in 18 of these patients with a mean end-expiratory “pleural pressure” of 17.0 ± 2.9 cm H<sub>2</sub>O. Airway pressure release ventilation (APRV) was used to ventilate all the patients. Seven patients had a tracheotomy performed while in the ICU.</p>
         <p>Pulmonary function tests performed prior to the index hospitalization were available in 18 patients and 23 had PFTs performed after the index hospitalization. No patient showed evidence of obstructive lung disease or evidence of reversible airway disease. Pulmonary function tests were suggestive of restrictive pattern in all cases. The mean forced expiratory volume in one second (FEV<sub>1</sub>) was 1.06 ± 0.44 L, with a predicted percentage of 41% ± 13%, and the forced vital capacity (FVC) was 1.29 ± 0.54 L with a predicted percentage of 42% ± 11% with a FEV<sub>1</sub>/FVC ratio of 82% ± 6%. The total lung capacity (TLC) was 2.66 ± 0.9 L with a predicted percentage of 56% ± 15% and the residual volume was 1.25 ± 0.6 L, with a predicted percentage of 76% ± 20%. The patients’ pertinent laboratory data are provided in <xref ref-type="table" rid="table1-0885066612444261">Table 1</xref>. Twenty-five (41%) patients had CRI of whom 8 were receiving hemodialysis. On the basis of unexplained abnormalities of liver function tests, 39 patients (64%) were presumptively diagnosed with NASH (none previously diagnosed). Of these 39 patients, 18 had an elevated NH<sub>3</sub> in the absence of a transaminitis (mean NH<sub>3</sub> of 86 ± 22 ug/dL). The serum triglyceride concentration was 150 ± 70 mg/dL in those patients with NASH compared to 105 ± 36 mg/dL in those without NASH (<italic>P</italic> = .01); similarly, the serum ferritin was 460 ± 331 ng/mL in those with NASH compared to 130 ± 107 in those without NASH (<italic>P</italic> &lt; .001). All except 1 patient had a 25-OH vitamin D level below 30 ng/mL (mean of 13.5 ± 8.5 ng/mL). Echocardiography was performed on all patients during the index admission. The following echocardiographic data were obtained: ejection fraction (EF) 57% ± 14%, with 11 patients having an EF &lt;50%, LV mass index of 60.9 ± 21.8 g/m<sup>2.7</sup> with 43 (71%) patients having LV hypertrophy (RWT of 0.3 ± 0.1; eccentric in 42), left atrial systolic pressure 19.0 ± 6.6 mm Hg with 37 (61%) patients having echocardiographic features of LV diastolic dysfunction. The estimated mean pulmonary artery systolic pressure was 47 ± 18 mm Hg; 47 (77%) patients had pulmonary hypertension with 25 (41%) having moderate-to-severe pulmonary hypertension; all these patients had evidence of right ventricular volume overload. Two patients had previously undergone right heart catheterization which confirmed the presence of severe pulmonary hypertension.</p>
         <table-wrap id="table1-0885066612444261" position="float">
            <label>Table 1.</label>
            <caption>
               <p>Laboratory Data of Patients With Malignant Obesity Hypoventilation Syndrome.</p>
            </caption>
            <graphic alt-version="no" alternate-form-of="table1-0885066612444261" position="float" xlink:href="10.1177_0885066612444261-table1.tif" xlink:type="simple"/>
            <table>
               <thead>
                  <tr>
                     <th colspan="1" rowspan="1">
</th>
                     <th colspan="1" rowspan="1">All (n = 61)</th>
                     <th colspan="1" rowspan="1">Survived (n = 50)</th>
                     <th colspan="1" rowspan="1">Died (n = 11)</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td colspan="1" rowspan="1">Age (years)</td>
                     <td colspan="1" rowspan="1">59 ± 11</td>
                     <td colspan="1" rowspan="1">59 ± 12</td>
                     <td colspan="1" rowspan="1">63 ± 9</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">BMI, kg/m<sup>2</sup>
                     </td>
                     <td colspan="1" rowspan="1">48.9 ± 8.6</td>
                     <td colspan="1" rowspan="1">48.3 ± 8.2</td>
                     <td colspan="1" rowspan="1">51.3 ± 8.6</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">PaCO<sub>2</sub>, mm Hg</td>
                     <td colspan="1" rowspan="1">69.2 ± 17.4</td>
                     <td colspan="1" rowspan="1">67.4 ± 16.0</td>
                     <td colspan="1" rowspan="1">77.2 ± 21.4</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">HCO<sup>3−</sup>,meq/L</td>
                     <td colspan="1" rowspan="1">34.3 ± 5.1</td>
                     <td colspan="1" rowspan="1">34.5 ± 5.3</td>
                     <td colspan="1" rowspan="1">33.5 ± 4.2</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">Serum creatinine, mg/dL</td>
                     <td colspan="1" rowspan="1">1.7 ± 1.6</td>
                     <td colspan="1" rowspan="1">1.6 ± 1.5</td>
                     <td colspan="1" rowspan="1">2.0 ± 1.5</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">HbA1C, %</td>
                     <td colspan="1" rowspan="1">7.5 ± 1.8</td>
                     <td colspan="1" rowspan="1">7.6 ± 1.9</td>
                     <td colspan="1" rowspan="1">6.7 ± 0.7</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">TSH, mcu/mL</td>
                     <td colspan="1" rowspan="1">1.8 ± 1.0</td>
                     <td colspan="1" rowspan="1">1.6 ± 1.0</td>
                     <td colspan="1" rowspan="1">2.0 ± 0.89</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">Total cholesterol, mg/dL</td>
                     <td colspan="1" rowspan="1">174 ± 48</td>
                     <td colspan="1" rowspan="1">174 ± 46</td>
                     <td colspan="1" rowspan="1">171 ± 57</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">Triglyceride, mg/dL</td>
                     <td colspan="1" rowspan="1">135 ± 64</td>
                     <td colspan="1" rowspan="1">125 ± 45</td>
                     <td colspan="1" rowspan="1">174 ± 110<sup>
                           <xref ref-type="table-fn" rid="table-fn2-0885066612444261">a</xref>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">HDL, mg/dL</td>
                     <td colspan="1" rowspan="1">41 ± 17</td>
                     <td colspan="1" rowspan="1">42 ± 16</td>
                     <td colspan="1" rowspan="1">37 ± 19</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">25-OH vitamin D, ng/mL</td>
                     <td colspan="1" rowspan="1">13.5 ± 8.5</td>
                     <td colspan="1" rowspan="1">13.2 ± 8.0</td>
                     <td colspan="1" rowspan="1">14.7 ± 8.1</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">AST IU/L</td>
                     <td colspan="1" rowspan="1">36 ± 36</td>
                     <td colspan="1" rowspan="1">30 ± 23</td>
                     <td colspan="1" rowspan="1">59 ± 64<sup>
                           <xref ref-type="table-fn" rid="table-fn2-0885066612444261">a</xref>
                        </sup>
                     </td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">CRP, mg/dL</td>
                     <td colspan="1" rowspan="1">9.4 ± 6.9</td>
                     <td colspan="1" rowspan="1">8.9 ± 6.1</td>
                     <td colspan="1" rowspan="1">12.0 ± 10.4</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">NASH (%)</td>
                     <td colspan="1" rowspan="1">39 (64)</td>
                     <td colspan="1" rowspan="1">30 (60)</td>
                     <td colspan="1" rowspan="1">9 (82)</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">LV mass, g/m<sup>2.7</sup>
                     </td>
                     <td colspan="1" rowspan="1">60.9 ± 21.8</td>
                     <td colspan="1" rowspan="1">60.4 ± 20.4</td>
                     <td colspan="1" rowspan="1">62.9 ± 27.9</td>
                  </tr>
                  <tr>
                     <td colspan="1" rowspan="1">PA, systolic, mm Hg</td>
                     <td colspan="1" rowspan="1">47 ± 18</td>
                     <td colspan="1" rowspan="1">48 ± 18</td>
                     <td colspan="1" rowspan="1">44 ± 18</td>
                  </tr>
               </tbody>
            </table>
            <table-wrap-foot>
               <fn id="table-fn1-0885066612444261">
                  <p>Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; AST, aspartate transaminase; CRP, C-reactive protein; NASH, nonalcoholic steatohepatitis; LV, left ventricular; PA, pulmonary artery; TSH, thyroid stimulating hormone.</p>
               </fn>
               <fn id="table-fn2-0885066612444261">
                  <p>
                     <sup>a</sup> 
                     <italic>P</italic> = .02, for alive vs dead.</p>
               </fn>
            </table-wrap-foot>
         </table-wrap>
         <p>Eleven patients (18%) died during the index hospitalization. The clinical characteristics of the patients who died compared to those who survived their hospital stay are provided in <xref ref-type="table" rid="table1-0885066612444261">Table 1</xref>. The serum triglyceride and aspartate transaminase (AST) were the only recorded variables that differed significantly between survivors and nonsurvivors. During the 8-month period of the study, 4 patients were readmitted to the ICU while 5 remained hospitalized in our long-term ventilator facility.</p>
      </sec>
      <sec id="section3-0885066612444261">
         <title>Discussion</title>
         <p>During an 8-month period, 61 patients with severe OHS were admitted to our ICU with hypercapnic respiratory failure. All patients had severe multisystem disease directly associated with morbid obesity and 11 died (18%). These patients had been admitted to our hospital on multiple occasions during the previous 2 years (6 ± 7 occasions). Forty-six (75%) patients had been erroneously diagnosed and treated for COPD/asthma. Only 3 patients had been diagnosed with OHS, emphasizing that this disorder is frequently not recognized. The exponential increase in the prevalence of type III obesity in the United States may explain the large number of patients with severe OHS that were admitted to our ICU (8% of all admissions).<sup>
               <xref ref-type="bibr" rid="bibr1-0885066612444261">1</xref>,<xref ref-type="bibr" rid="bibr2-0885066612444261">2</xref>,<xref ref-type="bibr" rid="bibr17-0885066612444261">17</xref>
            </sup> Unfortunately, most of these patients were misdiagnosed and the malignant nature of their disorder was not recognized.</p>
         <p>We believe our study to be the largest and most comprehensive evaluation of patients with severe OHS admitted to the ICU. Nowbar and colleagues screened 4332 consecutive hospitalized patients of whom 47 were considered to have OHS.<sup>
               <xref ref-type="bibr" rid="bibr9-0885066612444261">9</xref>
            </sup> Nineteen of these patients were admitted to the ICU and 3 required mechanical ventilation. Seven patients met the criteria for obstructive lung disease (FEV<sub>1</sub>/FVC &lt;70% with FEV1 &lt;50% predicted) and probably had the “overlap syndrome,” while the remainder had evidence of restrictive lung disease; 30 (64%) patients were receiving diuretics and 15 (32%) s were being treated for heart failure. Kessler and colleagues studied 34 patients with OHS over a 7-year period who were admitted to their pulmonary and sleep department (in Strasbourg, France).<sup>
               <xref ref-type="bibr" rid="bibr18-0885066612444261">18</xref>
            </sup> While detailed clinical information was lacking, their patients were not as obese mean BMI 40 ± 8 kg/m<sup>2</sup>) and had less comorbid disease than our cohort of patients. Similarly Berg and colleagues described 20 patients with OHS who were studied at sleep centers in the Province of Manitoba, Canada, over a 6-year period.<sup>
               <xref ref-type="bibr" rid="bibr19-0885066612444261">19</xref>
            </sup> The patient characteristics in this study were similar to those reported by Kessler and colleagues. We measured intraesophageal pressure, as a surrogate for intrapleural pressure in 18 patients who underwent mechanical ventilation.<sup>
               <xref ref-type="bibr" rid="bibr13-0885066612444261">13</xref>
            </sup> The mean end-expiratory esophageal pressure was 17 ± 2.9 cm H<sub>2</sub>O. Patients need to overcome this high intrapleural pressure to initiate a breath, and this may partly explain the increased work of breathing and hypoventilation in patients with OHS.<sup>
               <xref ref-type="bibr" rid="bibr20-0885066612444261">20</xref>
            </sup> Furthermore, this data suggests that high levels of Positive End Expiratory Pressure (PEEP) and expiratory Positive Airway Pressure (ePAP) may be required to prevent end-expiratory airway collapse in patients with OHS who are being mechanically ventilated or treated with BiPAP. All our patients were ventilated using APRV. We believe that APRV may be the ideal ventilatory mode in morbidly obese patients with respiratory failure. The increased mean alveolar pressure (above the intrapleural pressure) with short release time will prevent de-recruitment of lung units, while at the same time preventing alveolar overdistension.<sup>
               <xref ref-type="bibr" rid="bibr21-0885066612444261">21</xref>
            </sup> In addition, patients receiving APRV require minimal sedation which is advantageous in patients with decreased respiratory drive.</p>
         <p>Our study emphasizes that OHS is a systemic illness involving many organ systems with complicated interactions between these systems.<sup>
               <xref ref-type="bibr" rid="bibr22-0885066612444261">22</xref>,<xref ref-type="bibr" rid="bibr23-0885066612444261">23</xref>
            </sup> The organ system derangements include hypercapnic respiratory failure, systemic hypertension, LV hypertrophy with diastolic dysfunction, pulmonary hypertension, right ventricular volume overload, CRI, and NASH. We have coined the term malignant obesity hypoventilation syndrome (MOHS) to describe patients with class III obesity who have this constellation of clinical features. The pathophysiology of MOHS is related to the complex interactions and feedback loops between visceral obesity, leptin signaling, insulin resistance, alternation in gonadal hormones, and decreased hypothalamic Corticotrophin releasing hormone (CRH) release, hypoxia, oxidative stress, high sympathetic tone, hypercytokinemia (with a chronic proinflammatory state), hypoxia, vitamin D deficiency, endothelial dysfunction, and platelet activation together with a hypercoaguable state.<sup>
               <xref ref-type="bibr" rid="bibr22-0885066612444261">22</xref>,<xref ref-type="bibr" rid="bibr24-0885066612444261">24</xref>
            </sup>
         </p>
         <p>In our study 71% of patients had LV hypertrophy, 61% had LV diastolic dysfunction, and 77% had pulmonary hypertension. The alterations of cardiac function in patients with severe obesity are complex due to the frequent presence of comorbid conditions including systemic hypertension, diabetes, and hyperlipidemia.<sup>
               <xref ref-type="bibr" rid="bibr25-0885066612444261">25</xref>
            </sup> However, obesity is an independent risk factor for LV hypertrophy and dysfunction.<sup>
               <xref ref-type="bibr" rid="bibr26-0885066612444261">26</xref>
               <xref ref-type="bibr" rid="bibr27-0885066612444261"/>
               <xref ref-type="bibr" rid="bibr28-0885066612444261"/>–<xref ref-type="bibr" rid="bibr29-0885066612444261">29</xref>
            </sup> Left ventricular hypertrophy is related to the increased cardiac output associated with obesity as well as the effect of adipokines (leptin, adiponectin, cardiotrophin 1) on myocyte function.<sup>
               <xref ref-type="bibr" rid="bibr29-0885066612444261">29</xref>
               <xref ref-type="bibr" rid="bibr30-0885066612444261"/>–<xref ref-type="bibr" rid="bibr31-0885066612444261">31</xref>
            </sup>. In addition, chronic hypoxia itself may also induce LV hypertrophy. Sugerman and colleagues performed right heart catheterization in 46 morbidly obese patients (26 with OHS) undergoing weight loss surgery.<sup>
               <xref ref-type="bibr" rid="bibr32-0885066612444261">32</xref>
            </sup> Pulmonary hypertension was diagnosed in 88% of the patients with OHS as compared to 35% in those without OHS. Of the 23 patients with OHS and pulmonary hypertension, 14 (61%) had a pulmonary artery occlusion pressure greater than 18 mm Hg. None of the patients without OHS had an elevated pulmonary artery occlusion pressure (PAOP). This data suggests that both hypoxia with pulmonary vasoconstriction and increased left atrial pressure (related to LV diastolic dysfunction) are responsible for the severe pulmonary hypertension seen in patients with OHS.<sup>
               <xref ref-type="bibr" rid="bibr33-0885066612444261">33</xref>
            </sup>
         </p>
         <p>On the basis of unexplained abnormalities of liver function tests 39 patients (64%) were presumptively diagnosed with NASH. It is noteworthy that of these 39 patients, 18 had an elevated NH<sub>3</sub> in the absence of a transaminitis (mean NH<sub>3</sub> of 88 ± 22 ug/dL). The patients with NASH had markedly elevated ferritin levels, which supports the diagnosis of NASH in these patients. Hyperferritinemia has previously been shown to be a useful diagnostic biomarker for NASH.<sup>
               <xref ref-type="bibr" rid="bibr34-0885066612444261">34</xref>,<xref ref-type="bibr" rid="bibr35-0885066612444261">35</xref>
            </sup> However, as liver biopsies were not performed in any of our patients, we were unable to confirm the diagnosis. It is possible that our patient’s hepatic dysfunction was caused in part by hepatic congestion due to right-sided volume overload. The prevalence of NASH in patients with OHS has not been previously reported. However, Akashiba and colleagues noted that patients with OHS had higher serum transaminases than patients with OSA alone.<sup>
               <xref ref-type="bibr" rid="bibr36-0885066612444261">36</xref>
            </sup> It is noteworthy that in our cohort both increased triglyceride and AST levels were predictive of death; these variables are markers of more severe steatohepatitis.<sup>
               <xref ref-type="bibr" rid="bibr37-0885066612444261">37</xref>
               <xref ref-type="bibr" rid="bibr38-0885066612444261"/>
               <xref ref-type="bibr" rid="bibr39-0885066612444261"/>–<xref ref-type="bibr" rid="bibr40-0885066612444261">40</xref>
            </sup>
         </p>
         <p>Twenty-five (41%) patients in our cohort had CRI. While all of these patients had comorbidities (hypertension and diabetes) that increased the risk of kidney disease, obesity itself has been reported to be an independent risk factor for development and progression of renal damage.<sup>
               <xref ref-type="bibr" rid="bibr41-0885066612444261">41</xref>
            </sup> The BMI has been demonstrated to be an independent predictor of the rate of decline in renal function in patients with nondiabetic renal disease.<sup>
               <xref ref-type="bibr" rid="bibr42-0885066612444261">42</xref>
            </sup> In 1974, Weisinger et al first reported an association between obesity and nephrotic syndrome that remitted with weight loss and returned with weight gain.<sup>
               <xref ref-type="bibr" rid="bibr43-0885066612444261">43</xref>
            </sup> The renal histology was that of idiopathic focal segmental glomerulosclerosis (FSGS). The term obesity-related glomerulopathy is now used to describe this secondary form of FSGS. Serra and colleagues analyzed renal biopsies from obese patients with normal renal function presenting for bariatric surgery.<sup>
               <xref ref-type="bibr" rid="bibr44-0885066612444261">44</xref>
            </sup> Seventy-seven percent had some glomerular lesion including glomerulomegaly, FSGS, global sclerosis, podocyte hypertrophy. Body mass index (BMI) was a significant independent risk factor associated with the severity of glomerular lesions. Navaneethan and colleagues demonstrated an improvement in renal function following bariatric surgery.<sup>
               <xref ref-type="bibr" rid="bibr45-0885066612444261">45</xref>
            </sup> Adipocytes contain all the components of the renin–angiotensin–aldosterone system, plasminogen activator inhibitor, proinflammatory cytokines as well as adipocyte-specific metabolites such as free fatty acids, leptin, and adiponectin that contribute to the pathophysiologic renal hemodynamic and structural changes leading to obesity-related nephropathy.<sup>
               <xref ref-type="bibr" rid="bibr41-0885066612444261">41</xref>
            </sup>
         </p>
         <p>All but 1 of the patients in our study were severely vitamin D deficient (mean 25-OH vitamin D of 13.5 ± 8.5 ng/mL). Obesity is well recognized to be a risk factor for vitamin D deficiency.<sup>
               <xref ref-type="bibr" rid="bibr46-0885066612444261">46</xref>
               <xref ref-type="bibr" rid="bibr47-0885066612444261"/>–<xref ref-type="bibr" rid="bibr48-0885066612444261">48</xref>
            </sup> Decreased sun exposure, increased skin pigmentation and sequestration of vitamin D (fat soluble) in fat stores have been postulated to explain this finding.<sup>
               <xref ref-type="bibr" rid="bibr46-0885066612444261">46</xref>
               <xref ref-type="bibr" rid="bibr47-0885066612444261"/>–<xref ref-type="bibr" rid="bibr48-0885066612444261">48</xref>
            </sup> However, the relationship between vitamin D deficiency, obesity, and the metabolic syndrome are complex.<sup>
               <xref ref-type="bibr" rid="bibr49-0885066612444261">49</xref>,<xref ref-type="bibr" rid="bibr50-0885066612444261">50</xref>
            </sup> Vitamin D deficiency has been implicated in the pathophysiology of insulin resistance,<sup>
               <xref ref-type="bibr" rid="bibr49-0885066612444261">49</xref>,<xref ref-type="bibr" rid="bibr50-0885066612444261">50</xref>
            </sup> with vitamin D supplementation improving glycemic control in patients with diabetes.<sup>
               <xref ref-type="bibr" rid="bibr51-0885066612444261">51</xref>
            </sup> Tzotzas et al have reported rising serum 25-OH vitamin D levels after weight loss in obese women.<sup>
               <xref ref-type="bibr" rid="bibr52-0885066612444261">52</xref>
            </sup> In this study, the increased 25-OH vitamin D levels were associated with improved insulin resistance. In addition, prospective studies have demonstrated that children who are vitamin D deficient are at a higher risk of becoming obese.<sup>
               <xref ref-type="bibr" rid="bibr53-0885066612444261">53</xref>
            </sup> Low serum vitamin D levels have been suggested to partly explain the association of obesity with an increased risk of cancer.<sup>
               <xref ref-type="bibr" rid="bibr54-0885066612444261">54</xref>
            </sup>
         </p>
         <p>While noninvasive positive pressure ventilation is likely to improve gas exchange and clinical symptoms,<sup>
               <xref ref-type="bibr" rid="bibr55-0885066612444261">55</xref>
               <xref ref-type="bibr" rid="bibr56-0885066612444261"/>–<xref ref-type="bibr" rid="bibr57-0885066612444261">57</xref>
            </sup> and while it may improve insulin resistance and hypertension it will not reverse obesity nor the significant organ dysfunction associated with MOHS. Weight loss is the most important element in the management of MOHS and treating MOHS without achieving significant weight loss is unlikely to reduce the significant morbidity and mortality associated with this syndrome. Weight loss is often difficult to achieve and maintain by medical management. Bariatric surgery is the most effective approach to achieving more substantial degrees of weight loss and maintaining this loss over longer periods.<sup>
               <xref ref-type="bibr" rid="bibr58-0885066612444261">58</xref>
            </sup> Bariatric surgery would therefore appear to be the treatment of choice for MOHS. A substantial body of evidence has accumulated showing that a variety of bariatric operations result in highly significant, reproducible, and long-lasting improvement or remission of type 2 diabetes in severely obese patients.<sup>
               <xref ref-type="bibr" rid="bibr59-0885066612444261">59</xref>
            </sup> In addition, bariatric surgery has been demonstrated to improve OSA, pulmonary function, pulmonary hypertension, and reverse LV hypertrophy.<sup>
               <xref ref-type="bibr" rid="bibr28-0885066612444261">28</xref>,<xref ref-type="bibr" rid="bibr60-0885066612444261">60</xref>
               <xref ref-type="bibr" rid="bibr61-0885066612444261"/>–<xref ref-type="bibr" rid="bibr62-0885066612444261">62</xref>
            </sup> Furthermore, bariatric surgery is associated with a significant improvement in transaminitis, steatosis, inflammation, and fibrosis in patients with NASH.<sup>
               <xref ref-type="bibr" rid="bibr63-0885066612444261">63</xref>
            </sup> Earlier recognition of patients with MOHS and aggressive measures to induce weight loss could offer the potential to improve the outcome and resource utilization of these patients.</p>
         <p>Our study has a number of limitations. The presence of edema may have increased the patients’ admission weight; however, this is likely to have a small impact on the patients’ BMI. Echocardiographic estimation of pulmonary artery systolic pressure may overestimate the true pressures.<sup>
               <xref ref-type="bibr" rid="bibr64-0885066612444261">64</xref>
            </sup> However, all the patients with moderate-to-severe pulmonary hypertension had evidence of right ventricular volume overload.</p>
         <p>In conclusion, we have demonstrated that the MOHS is a common multisystem disorder, that is frequently misdiagnosed and associated with significant morbidity and mortally and utilization of health care resources. Patients with MOHS should be evaluated for bariatric surgery as this intervention is likely to improve the outcome of this potentially fatal disease.</p>
      </sec>
   </body>
   <back>
      <fn-group>
         <fn fn-type="conflict" id="fn1-0885066612444261">
            <label>Declaration of Conflicting Interests</label>
            <p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
         </fn>
         <fn fn-type="financial-disclosure" id="fn2-0885066612444261">
            <label>Funding</label>
            <p>The author(s) received no financial support for the research, authorship, and/or publication of this article </p>
         </fn>
      </fn-group>
      <ref-list>
         <title>References</title>
         <ref id="bibr1-0885066612444261">
            <label>1</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Finucane</surname>
                     <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Stevens</surname>
                     <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cowan</surname>
                     <given-names>MJ</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>National, regional, and global trends in body-mass index since 1980: systemtic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants</article-title>. <source>Lancet</source>. <year>2011</year>;<volume>377</volume>(<issue>9765</issue>):<fpage>557</fpage>–<lpage>567</lpage>.</citation>
         </ref>
         <ref id="bibr2-0885066612444261">
            <label>2</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Flegal</surname>
                     <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Carroll</surname>
                     <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ogden</surname>
                     <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Curtin</surname>
                     <given-names>LR</given-names>
                  </name>
               </person-group>. <article-title>Prevalence and trends in obesity among US adults, 1999-2008</article-title>. <source>JAMA</source>. <year>2010</year>;<volume>303</volume>(<issue>3</issue>):<fpage>235</fpage>–<lpage>241</lpage>.</citation>
         </ref>
         <ref id="bibr3-0885066612444261">
            <label>3</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Calle</surname>
                     <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Thun</surname>
                     <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Petrelli</surname>
                     <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Rodriguez</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Heath</surname>
                     <given-names>CW</given-names>
                     <suffix>Jr</suffix>
                  </name>
               </person-group>. <article-title>Body-mass index and mortality in a prospective cohort of U.S. adults</article-title>. <source>N Engl J Med</source>. <year>1999</year>;<volume>341</volume>(<issue>15</issue>):<fpage>1097</fpage>–<lpage>1105</lpage>.</citation>
         </ref>
         <ref id="bibr4-0885066612444261">
            <label>4</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>de Gonzalez</surname>
                     <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hartge</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cerhan</surname>
                     <given-names>JR</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Body-Mass index and mortality among 1.46 million white adults</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>363</volume>(<issue>23</issue>):<fpage>2211</fpage>–<lpage>2219</lpage>.</citation>
         </ref>
         <ref id="bibr5-0885066612444261">
            <label>5</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Flegal</surname>
                     <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Graubard</surname>
                     <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Williamson</surname>
                     <given-names>DF</given-names>
                  </name>
               </person-group>. <article-title>Cause-specific excess deaths associated with underweight, overweight, and obesity</article-title>. <source>JAMA</source>. <year>2007</year>;<volume>298</volume>(<issue>17</issue>):<fpage>2028</fpage>–<lpage>2037</lpage>.</citation>
         </ref>
         <ref id="bibr6-0885066612444261">
            <label>6</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Piper</surname>
                     <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Grunstein</surname>
                     <given-names>RR</given-names>
                  </name>
               </person-group>. <article-title>Obesity hypoventilation syndrome. Mechanisms and management</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2011</year>;<volume>183</volume>(<issue>3</issue>):<fpage>292</fpage>–<lpage>298</lpage>.</citation>
         </ref>
         <ref id="bibr7-0885066612444261">
            <label>7</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Mokhlesi</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Tulaimat</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Faibussowitsch</surname>
                     <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Wang</surname>
                     <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Evans</surname>
                     <given-names>AT.</given-names>
                  </name>
               </person-group>. <article-title>Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea</article-title>. <source>Sleep Breath</source>. <year>2007</year>;<volume>11</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>124</lpage>.</citation>
         </ref>
         <ref id="bibr8-0885066612444261">
            <label>8</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Kaw</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hernandez</surname>
                     <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Walker</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Aboussouan</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mokhlesi</surname>
                     <given-names>B</given-names>
                  </name>
               </person-group>. <article-title>Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies</article-title>. <source>Chest</source>. <year>2009</year>;<volume>136</volume>(<issue>3</issue>):<fpage>787</fpage>–<lpage>796</lpage>.</citation>
         </ref>
         <ref id="bibr9-0885066612444261">
            <label>9</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Nowbar</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Burkart</surname>
                     <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Gonzales</surname>
                     <given-names>R</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome</article-title>. <source>Am J Med</source>. <year>2004</year>;<volume>116</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>7</lpage>.</citation>
         </ref>
         <ref id="bibr10-0885066612444261">
            <label>10</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Trakada</surname>
                     <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Steiropoulos</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nena</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Constandinidis</surname>
                     <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bouros</surname>
                     <given-names>D</given-names>
                  </name>
               </person-group>. <article-title>Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece</article-title>. <source>Sleep Breath</source>. <year>2010</year>;<volume>14</volume>(<issue>4</issue>):<fpage>381</fpage>–<lpage>386</lpage>.</citation>
         </ref>
         <ref id="bibr11-0885066612444261">
            <label>11</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Resta</surname>
                     <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Foschino Barbaro</surname>
                     <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Brindicci</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nocerino</surname>
                     <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Caratozzolo</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Carbonara</surname>
                     <given-names>M</given-names>
                  </name>
               </person-group>. <article-title>Hypercapnia in overlap syndrome: possible determinant factors</article-title>. <source>Sleep Breath</source>. <year>2002</year>;<volume>6</volume>(<issue>1</issue>):<fpage>11</fpage>–<lpage>18</lpage>.</citation>
         </ref>
         <ref id="bibr12-0885066612444261">
            <label>12</label>
            <citation citation-type="web" xlink:type="simple">
               <collab collab-type="author" xlink:type="simple">Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Insitute of Medicine</collab>. <source>Dietary Reference Intakes for Calicum, and VItamin D</source>. <ext-link ext-link-type="uri" xlink:href="http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx" xlink:type="simple">http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx</ext-link>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy Press</publisher-name>; <year>2010</year>.</citation>
         </ref>
         <ref id="bibr13-0885066612444261">
            <label>13</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Talmor</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sarge</surname>
                     <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Malhotra</surname>
                     <given-names>A</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Mechanical ventilation guided by esophageal pressure in acute lung injury</article-title>. <source>N Engl J Med</source>. <year>2008</year>;<volume>359</volume>(<issue>20</issue>):<fpage>2095</fpage>–<lpage>2104</lpage>.</citation>
         </ref>
         <ref id="bibr14-0885066612444261">
            <label>14</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Cuspidi</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Giudici</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Negri</surname>
                     <given-names>F</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Improving cardiovascular risk stratification in essential hypertensive patients by indexing left ventricular mass to height(2.7)</article-title>. <source>J Hypertens</source>. <year>2009</year>;<volume>27</volume>(<issue>12</issue>):<fpage>2465</fpage>–<lpage>2471</lpage>.</citation>
         </ref>
         <ref id="bibr15-0885066612444261">
            <label>15</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Quinones</surname>
                     <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Otto</surname>
                     <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Stoddard</surname>
                     <given-names>M</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography</article-title>. <source>J Am Soc Echocardiogr</source>. <year>2002</year>;<volume>15</volume>(<issue>2</issue>):<fpage>167</fpage>–<lpage>184</lpage>.</citation>
         </ref>
         <ref id="bibr16-0885066612444261">
            <label>16</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Grundy</surname>
                     <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cleeman</surname>
                     <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Daniels</surname>
                     <given-names>SR</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement</article-title>. <source>Circulation</source>. <year>2005</year>;<volume>112</volume>(<issue>17</issue>):<fpage>2735</fpage>–<lpage>2752</lpage>.</citation>
         </ref>
         <ref id="bibr17-0885066612444261">
            <label>17</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Freedman</surname>
                     <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Khan</surname>
                     <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Serdula</surname>
                     <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Galuska</surname>
                     <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Dietz</surname>
                     <given-names>WH</given-names>
                  </name>
               </person-group>. <article-title>Trends and correlates of class 3 obesity in the United States from 1990 through 2000</article-title>. <source>JAMA</source>. <year>2002</year>;<volume>288</volume>(<issue>14</issue>):<fpage>1758</fpage>–<lpage>1761</lpage>.</citation>
         </ref>
         <ref id="bibr18-0885066612444261">
            <label>18</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Kessler</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chaouat</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Schinkewitch</surname>
                     <given-names>P</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases</article-title>. <source>Chest</source>. <year>2001</year>;<volume>120</volume>(<issue>2</issue>):<fpage>369</fpage>–<lpage>376</lpage>.</citation>
         </ref>
         <ref id="bibr19-0885066612444261">
            <label>19</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Berg</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Delaive</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Manfreda</surname>
                     <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Walld</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kryger</surname>
                     <given-names>MH.</given-names>
                  </name>
               </person-group>. <article-title>The use of health-care resources in obesity-hypoventilation syndrome</article-title>. <source>Chest</source>. <year>2001</year>;<volume>120</volume>(<issue>2</issue>):<fpage>377</fpage>–<lpage>383</lpage>.</citation>
         </ref>
         <ref id="bibr20-0885066612444261">
            <label>20</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Sharp</surname>
                     <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Henry</surname>
                     <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sweany</surname>
                     <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Meadows</surname>
                     <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pietras</surname>
                     <given-names>RJ</given-names>
                  </name>
               </person-group>. <article-title>The total work of breathing in normal and obese men</article-title>. <source>J Clin Invest</source>. <year>1964</year>;<volume>43</volume>:<fpage>728</fpage>–<lpage>739</lpage>.</citation>
         </ref>
         <ref id="bibr21-0885066612444261">
            <label>21</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hirani</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cavallazzi</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Shnister</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Paul</surname>
                     <given-names>EM</given-names>
                  </name>
               </person-group>. <article-title>Airway pressure release ventilation (APRV) for theatment of severe life-threatening ARDS in a morbidly obese patient</article-title>. <source>Crit Care Shock</source>. <year>2008</year>;<volume>11</volume>(<issue>4</issue>):<fpage>132</fpage>–<lpage>136</lpage>.</citation>
         </ref>
         <ref id="bibr22-0885066612444261">
            <label>22</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Vgontzas</surname>
                     <given-names>AN</given-names>
                  </name>
               </person-group>. <article-title>Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?</article-title> 
               <source>Arch Physiol Biochem</source>. <year>2008</year>;<volume>114</volume>(<issue>4</issue>):<fpage>211</fpage>–<lpage>223</lpage>.</citation>
         </ref>
         <ref id="bibr23-0885066612444261">
            <label>23</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Zamarron</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Garcia Paz</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Riveiro</surname>
                     <given-names>A</given-names>
                  </name>
               </person-group>. <article-title>Obstructive sleep apnea syndrome is a systemic disease. Current evidence</article-title>. <source>Eur J Intern Med</source>. <year>2008</year>;<volume>19</volume>(<issue>6</issue>):<fpage>390</fpage>–<lpage>398</lpage>.</citation>
         </ref>
         <ref id="bibr24-0885066612444261">
            <label>24</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Nguyen</surname>
                     <given-names>NT</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Magno</surname>
                     <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lane</surname>
                     <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hinojosa</surname>
                     <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lane</surname>
                     <given-names>JSI</given-names>
                  </name>
               </person-group>. <article-title>Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004</article-title>. <source>J Am Coll Surg</source>. <year>2008</year>;<volume>207</volume>(<issue>6</issue>):<fpage>928</fpage>–<lpage>934</lpage>.</citation>
         </ref>
         <ref id="bibr25-0885066612444261">
            <label>25</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Masaidi</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cuspidi</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Negri</surname>
                     <given-names>F</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Left and right ventricular structural changes in obese hypertensives</article-title>. <source>Blood Press</source>. <year>2009</year>;<volume>18</volume>(<issue>1-2</issue>):<fpage>23</fpage>–<lpage>29</lpage>.</citation>
         </ref>
         <ref id="bibr26-0885066612444261">
            <label>26</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Rodrigues</surname>
                     <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Baldo</surname>
                     <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sa</surname>
                     <given-names>CR</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Anthropometric measures of increased central and overall adiposity in association with echocardiographic left ventricular hypertrophy</article-title>. <source>Hypertens Res</source>. <year>2010</year>;<volume>33</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>87</lpage>.</citation>
         </ref>
         <ref id="bibr27-0885066612444261">
            <label>27</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Libhaber</surname>
                     <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Norton</surname>
                     <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Majane</surname>
                     <given-names>OH</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity</article-title>. <source>Am J Cardiol</source>. <year>2009</year>;<volume>104</volume>(<issue>11</issue>):<fpage>1527</fpage>–<lpage>1533</lpage>.</citation>
         </ref>
         <ref id="bibr28-0885066612444261">
            <label>28</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Jhaveri</surname>
                     <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pond</surname>
                     <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hauser</surname>
                     <given-names>TH</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Cardiac remodeling after substantial weight loss: a prospective cardiac magnetic resonance study after bariatric surgery</article-title>. <source>Surg Obes Relat Dis</source>. <year>2009</year>;<volume>5</volume>(<issue>6</issue>):<fpage>648</fpage>–<lpage>652</lpage>.</citation>
         </ref>
         <ref id="bibr29-0885066612444261">
            <label>29</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Ebinc</surname>
                     <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ebinc</surname>
                     <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ozkurt</surname>
                     <given-names>ZN</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Impact of adiponectin on left ventricular mass index in non-complicated obese subjects</article-title>. <source>Endocr J</source>. <year>2008</year>;<volume>55</volume>(<issue>3</issue>):<fpage>523</fpage>–<lpage>528</lpage>.</citation>
         </ref>
         <ref id="bibr30-0885066612444261">
            <label>30</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Malavazos</surname>
                     <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ermetici</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Morricone</surname>
                     <given-names>L</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Association of increased plasma cardiotrophin-1 with left ventricular mass indexes in normotensive morbid obesity</article-title>. <source>Hypertension</source>. <year>2008</year>;<volume>51</volume>(<issue>2</issue>):<fpage>e8</fpage>–<lpage>e9</lpage>.</citation>
         </ref>
         <ref id="bibr31-0885066612444261">
            <label>31</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Owan</surname>
                     <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Litwin</surname>
                     <given-names>SE</given-names>
                  </name>
               </person-group>. <article-title>Is there a cardiomyopathy of obesity?</article-title> 
               <source>Curr Heart Fail Rep</source>. <year>2007</year>;<volume>4</volume>(<issue>4</issue>):<fpage>221</fpage>–<lpage>228</lpage>.</citation>
         </ref>
         <ref id="bibr32-0885066612444261">
            <label>32</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Sugerman</surname>
                     <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Baron</surname>
                     <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Fairman</surname>
                     <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Evans</surname>
                     <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Vetrovec</surname>
                     <given-names>GW.</given-names>
                  </name>
               </person-group> 
               <article-title>Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss</article-title>. <source>Ann Surg</source>. <year>1988</year>;<volume>207</volume>(<issue>5</issue>):<fpage>604</fpage>–<lpage>613</lpage>.</citation>
         </ref>
         <ref id="bibr33-0885066612444261">
            <label>33</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Leung</surname>
                     <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Moondra</surname>
                     <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Catherwood</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Andrus</surname>
                     <given-names>BW</given-names>
                  </name>
               </person-group>. <article-title>Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction</article-title>. <source>Am J Cardiol</source>. <year>2010</year>;<volume>106</volume>(<issue>2</issue>):<fpage>284</fpage>–<lpage>286</lpage>.</citation>
         </ref>
         <ref id="bibr34-0885066612444261">
            <label>34</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Yoneda</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nozaki</surname>
                     <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Endo</surname>
                     <given-names>H</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation</article-title>. <source>Dig Dis Sci</source>. <year>2010</year>;<volume>55</volume>(<issue>3</issue>):<fpage>808</fpage>–<lpage>814</lpage>.</citation>
         </ref>
         <ref id="bibr35-0885066612444261">
            <label>35</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Zelber-Sagi</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Nitzan-Kaluski</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Halpern</surname>
                     <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Oren</surname>
                     <given-names>R</given-names>
                  </name>
               </person-group>. <article-title>NAFLD and hyperinsulinemia are major determinants of serum ferritin levels</article-title>. <source>J Hepatol</source>. <year>2007</year>;<volume>46</volume>(<issue>4</issue>):<fpage>700</fpage>–<lpage>707</lpage>.</citation>
         </ref>
         <ref id="bibr36-0885066612444261">
            <label>36</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Akashiba</surname>
                     <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Akahoshi</surname>
                     <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kawahara</surname>
                     <given-names>S</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study</article-title>. <source>Intern Med</source>. <year>2006</year>;<volume>45</volume>(<issue>20</issue>):<fpage>1121</fpage>–<lpage>1125</lpage>.</citation>
         </ref>
         <ref id="bibr37-0885066612444261">
            <label>37</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Pagano</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pacini</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Musso</surname>
                     <given-names>G</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association</article-title>. <source>Hepatology</source>. <year>2002</year>;<volume>35</volume>(<issue>2</issue>):<fpage>367</fpage>–<lpage>372</lpage>.</citation>
         </ref>
         <ref id="bibr38-0885066612444261">
            <label>38</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Kashyap</surname>
                     <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Diab</surname>
                     <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Baker</surname>
                     <given-names>AR</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort</article-title>. <source>Obesity</source>. <year>2009</year>;<volume>17</volume>(<issue>9</issue>):<fpage>1696</fpage>–<lpage>1701</lpage>.</citation>
         </ref>
         <ref id="bibr39-0885066612444261">
            <label>39</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Assy</surname>
                     <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kaita</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mymin</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Levy</surname>
                     <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Rosser</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Minuk</surname>
                     <given-names>G</given-names>
                  </name>
               </person-group>. <article-title>Fatty infiltration of liver in hyperlipidemic patients</article-title>. <source>Dig Dis Sci</source>. <year>2000</year>;<volume>45</volume>(<issue>10</issue>):<fpage>1929</fpage>–<lpage>1934</lpage>.</citation>
         </ref>
         <ref id="bibr40-0885066612444261">
            <label>40</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Ulitsky</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ananthakrishnan</surname>
                     <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Komorowski</surname>
                     <given-names>R</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients</article-title>. <source>Obes Surg</source>. <year>2010</year>;<volume>20</volume>(<issue>6</issue>):<fpage>685</fpage>–<lpage>691</lpage>.</citation>
         </ref>
         <ref id="bibr41-0885066612444261">
            <label>41</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Hunley</surname>
                     <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ma</surname>
                     <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kon</surname>
                     <given-names>V</given-names>
                  </name>
               </person-group>. <article-title>Scope and mechanisms of obesity-related renal disease</article-title>. <source>Curr Opin Nephrol Hypertens</source>. <year>2010</year>;<volume>19</volume>(<issue>3</issue>):<fpage>227</fpage>–<lpage>234</lpage>.</citation>
         </ref>
         <ref id="bibr42-0885066612444261">
            <label>42</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Othman</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kawar</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>El Nahas</surname>
                     <given-names>AM</given-names>
                  </name>
               </person-group>. <article-title>Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study</article-title>. <source>Nephron Clin Pract</source>. <year>2009</year>;<volume>113</volume>(<issue>1</issue>):<fpage>c16</fpage>–<lpage>c23</lpage>.</citation>
         </ref>
         <ref id="bibr43-0885066612444261">
            <label>43</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Weisinger</surname>
                     <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kempson</surname>
                     <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Eldridge</surname>
                     <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Swenson</surname>
                     <given-names>RS</given-names>
                  </name>
               </person-group>. <article-title>The nephrotic syndrome: a complication of massive obesity</article-title>. <source>Ann Intern Med</source>. <year>1974</year>;<volume>81</volume>(<issue>4</issue>):<fpage>440</fpage>–<lpage>447</lpage>.</citation>
         </ref>
         <ref id="bibr44-0885066612444261">
            <label>44</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Serra</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Romero</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lopez</surname>
                     <given-names>D</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Renal injury in the extremely obese patients with normal renal function</article-title>. <source>Kidney Int</source>. <year>2008</year>;<volume>73</volume>(<issue>8</issue>):<fpage>947</fpage>–<lpage>955</lpage>.</citation>
         </ref>
         <ref id="bibr45-0885066612444261">
            <label>45</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Navaneethan</surname>
                     <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Yehnert</surname>
                     <given-names>H</given-names>
                  </name>
               </person-group>. <article-title>Bariatric surgery and progression of chronic kidney disease</article-title>. <source>Surg Obes Relat Dis</source>. <year>2009</year>;<volume>5</volume>(<issue>6</issue>):<fpage>662</fpage>–<lpage>665</lpage>.</citation>
         </ref>
         <ref id="bibr46-0885066612444261">
            <label>46</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Jorde</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sneve</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Emaus</surname>
                     <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Figenschau</surname>
                     <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Grimnes</surname>
                     <given-names>G.</given-names>
                  </name>
               </person-group>. <article-title>Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study</article-title>. <source>Eur J Nutr</source>. <year>2010</year>;<volume>49</volume>(<issue>7</issue>):<fpage>401</fpage>–<lpage>407</lpage>.</citation>
         </ref>
         <ref id="bibr47-0885066612444261">
            <label>47</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Cheng</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Massaro</surname>
                     <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Fox</surname>
                     <given-names>CS</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study</article-title>. <source>Diabetes</source>. <year>2010</year>;<volume>59</volume>(<issue>1</issue>):<fpage>242</fpage>–<lpage>248</lpage>.</citation>
         </ref>
         <ref id="bibr48-0885066612444261">
            <label>48</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Fish</surname>
                     <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Beverstein</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Olson</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Reinhardt</surname>
                     <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Garren</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Gould</surname>
                     <given-names>J</given-names>
                  </name>
               </person-group>. <article-title>Vitamin D status of morbidly obese bariatric surgery patients</article-title>. <source>J Surg Res</source>. <year>2010</year>;<volume>164</volume>(<issue>2</issue>):<fpage>198</fpage>–<lpage>202</lpage>.</citation>
         </ref>
         <ref id="bibr49-0885066612444261">
            <label>49</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Baz-Hecht</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Goldfine</surname>
                     <given-names>AB</given-names>
                  </name>
               </person-group>. <article-title>The impact of vitamin D deficiency on diabetes and cardiovascular risk</article-title>. <source>Curr Opin Endocrinol Diabetes Obes</source>. <year>2010</year>;<volume>17</volume>(<issue>2</issue>):<fpage>113</fpage>–<lpage>119</lpage>.</citation>
         </ref>
         <ref id="bibr50-0885066612444261">
            <label>50</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Osei</surname>
                     <given-names>K</given-names>
                  </name>
               </person-group>. <article-title>25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes?</article-title> 
               <source>J Clin Endocrinol Metab</source>. <year>2010</year>;<volume>95</volume>(<issue>9</issue>):<fpage>4220</fpage>–<lpage>4222</lpage>.</citation>
         </ref>
         <ref id="bibr51-0885066612444261">
            <label>51</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Nikooyeh</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Neyestani</surname>
                     <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Farvid</surname>
                     <given-names>M</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial</article-title>. <source>Am J Clin Nutr</source>. <year>2011</year>;<volume>93</volume>(<issue>4</issue>):<fpage>764</fpage>–<lpage>771</lpage>.</citation>
         </ref>
         <ref id="bibr52-0885066612444261">
            <label>52</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Tzotzas</surname>
                     <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Papadopoulou</surname>
                     <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Tziomalos</surname>
                     <given-names>K</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2010</year>;<volume>95</volume>(<issue>9</issue>):<fpage>4251</fpage>–<lpage>4257</lpage>.</citation>
         </ref>
         <ref id="bibr53-0885066612444261">
            <label>53</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Gilbert-Diamond</surname>
                     <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Baylin</surname>
                     <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mora-Plazas</surname>
                     <given-names>M</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Vitamin D deficiency and anthropometric indicators of adiposity in school-age children: a prospective study</article-title>. <source>Am J Clin Nutr</source>. <year>2010</year>;<volume>92</volume>(<issue>6</issue>):<fpage>1446</fpage>–<lpage>1451</lpage>.</citation>
         </ref>
         <ref id="bibr54-0885066612444261">
            <label>54</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Lagunova</surname>
                     <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Porojnicu</surname>
                     <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Grant</surname>
                     <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bruland</surname>
                     <given-names>Ø</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Moan</surname>
                     <given-names>JE</given-names>
                  </name>
               </person-group>. <article-title>Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association?</article-title> 
               <source>Mol Nutr Food Res</source>. <year>2010</year>;<volume>54</volume>(<issue>8</issue>):<fpage>1127</fpage>–<lpage>1133</lpage>.</citation>
         </ref>
         <ref id="bibr55-0885066612444261">
            <label>55</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Priou</surname>
                     <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hamel</surname>
                     <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Person</surname>
                     <given-names>C</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome</article-title>. <source>Chest</source>. <year>2010</year>;<volume>138</volume>(<issue>1</issue>):<fpage>84</fpage>–<lpage>90</lpage>.</citation>
         </ref>
         <ref id="bibr56-0885066612444261">
            <label>56</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Perez de Llano</surname>
                     <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Golpe</surname>
                     <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Ortiz</surname>
                     <given-names>PM</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome</article-title>. <source>Chest</source>. <year>2005</year>;<volume>128</volume>(<issue>2</issue>):<fpage>587</fpage>–<lpage>594</lpage>.</citation>
         </ref>
         <ref id="bibr57-0885066612444261">
            <label>57</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Masa</surname>
                     <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Celli</surname>
                     <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Riesco</surname>
                     <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Hernández</surname>
                     <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sánchez De Cos</surname>
                     <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Disdier</surname>
                     <given-names>C.</given-names>
                  </name>
               </person-group>. <article-title>The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation</article-title>. <source>Chest</source>. <year>2001</year>;<volume>119</volume>(<issue>4</issue>):<fpage>1102</fpage>–<lpage>1107</lpage>.</citation>
         </ref>
         <ref id="bibr58-0885066612444261">
            <label>58</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Sjostrom</surname>
                     <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Narbro</surname>
                     <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sjostrom</surname>
                     <given-names>CD</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Effects of bariatric surgery on mortality in Swedish obese subjects</article-title>. <source>N Engl J Med</source>. <year>2007</year>;<volume>357</volume>(<issue>8</issue>):<fpage>741</fpage>–<lpage>752</lpage>.</citation>
         </ref>
         <ref id="bibr59-0885066612444261">
            <label>59</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Rubino</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Kaplan</surname>
                     <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Schauer</surname>
                     <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Cummings</surname>
                     <given-names>DE</given-names>
                  </name>
               </person-group>; <collab collab-type="author" xlink:type="simple">Diabetes Surgery Summit Delegates</collab>. <article-title>The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus</article-title>. <source>Ann Surg</source>. <year>2010</year>;<volume>251</volume>(<issue>3</issue>):<fpage>399</fpage>–<lpage>405</lpage>.</citation>
         </ref>
         <ref id="bibr60-0885066612444261">
            <label>60</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Greenburg</surname>
                     <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Lettieri</surname>
                     <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Eliasson</surname>
                     <given-names>AH</given-names>
                  </name>
               </person-group>. <article-title>Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis</article-title>. <source>Am J Med</source>. <year>2009</year>;<volume>122</volume>(<issue>6</issue>):<fpage>535</fpage>–<lpage>542</lpage>.</citation>
         </ref>
         <ref id="bibr61-0885066612444261">
            <label>61</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Lumachi</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Marzano</surname>
                     <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Fanti</surname>
                     <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Basso</surname>
                     <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Mazza</surname>
                     <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Chiara</surname>
                     <given-names>GB</given-names>
                  </name>
               </person-group>. <article-title>Hypoxemia and hypoventilation syndrome improvement after laparoscopic bariatric surgery in patients with morbid obesity</article-title>. <source>In Vivo</source>. <year>2010</year>;<volume>24</volume>(<issue>3</issue>):<fpage>329</fpage>–<lpage>331</lpage>.</citation>
         </ref>
         <ref id="bibr62-0885066612444261">
            <label>62</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Garza</surname>
                     <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Pellikka</surname>
                     <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Somers</surname>
                     <given-names>VK</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity</article-title>. <source>Am J Cardiol</source>. <year>2010</year>;<volume>105</volume>(<issue>4</issue>):<fpage>550</fpage>–<lpage>556</lpage>.</citation>
         </ref>
         <ref id="bibr63-0885066612444261">
            <label>63</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Dixon</surname>
                     <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Bhathal</surname>
                     <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                     <surname>O'Brien</surname>
                     <given-names>PE</given-names>
                  </name>
               </person-group>. <article-title>Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese</article-title>. <source>Gastroenterology</source>. <year>2001</year>;<volume>121</volume>(<issue>1</issue>):<fpage>91</fpage>–<lpage>100</lpage>.</citation>
         </ref>
         <ref id="bibr64-0885066612444261">
            <label>64</label>
            <citation citation-type="journal" xlink:type="simple">
               <person-group person-group-type="author">
                  <name name-style="western">
                     <surname>Badesch</surname>
                     <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Champion</surname>
                     <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                     <surname>Sanchez</surname>
                     <given-names>MA</given-names>
                  </name>
                  <etal/>
               </person-group>. <article-title>Diagnosis and assessment of pulmonary arterial hypertension</article-title>. <source>J Am Coll Cardiol</source>. <year>2009</year>;<volume>54</volume>(<issue>suppl 1</issue>):<fpage>S55</fpage>–<lpage>S66</lpage>.</citation>
         </ref>
      </ref-list>
   </back>
</article>